Search PubMed⌕ Search

Biomedical subjects

T Markestad

Publications and source records attributed to T Markestad.

115 records · Page 7Linked to original sources

Growth and development in children recovering from bronchopulmonary dysplasia.

Of 26 patients with bronchopulmonary dysplasia, 20 (77%) survived and were followed prospectively for two years post-term. Lower respiratory tract infections occurred in 17 of the 20 children (85%), and required hospitalization in ten (50%) during the first and in four (20%) during the second year. At two years post-term only two patients had significant respiratory symptoms at rest, but 78% had residual radiographic changes. The average weight and height at term were at or below the third percentile. Growth occurred at an accelerated rate with improvement of respiratory symptoms, with average weight reaching the third to tenth percentile for both sexes, and tenth to twenty-fifth percentile for height in the boys and the twenty-fifth percentile for the girls by two years post-term. Growth retardation was associated with severe and prolonged respiratory dysfunction. Fifteen (75%) were free of major developmental defects. Five had mean Bayley scores less than 85 at 18 months post-term; one also had hydrocephalus. Developmental outcome seems related to perinatal and neonatal events rather than to the presence or absence of BPD.

Bronchi↗

Effect of parathyroid hormone on vitamin D metabolism in osteopetrosis.

Indices of vitamin D metabolism were studied before and after infusion of bovine parathyroid hormone extract in three children with osteopetrosis. Basal serum concentrations of calcium, alkaline phosphatase, and 25-hydroxyvitamin D tended to be low. Serum immunoreactive parathyroid hormone levels were in the upper normal range in two patients. A marked increase in urinary cyclic adenosine 3':5'-monophosphate (cAMP) in all patients was solely due to an increase in the nephrogenous cAMP. The basal concentration of 1,25-dihydroxyvitamin D was clearly more than the upper limit of normal range in all three patients and increased after parathyroid extract infusion in one patient. The basal serum levels of 24,25-dihydroxyvitamin D were within normal limits and tended to decrease after parathyroid extract infusion in two of the patients. Parathyroid hormone and 1,25-dihydroxyvitamin D act in concert to increase calcium resorption from bone, and the increased serum levels of both these factors may reflect lack, or unresponsiveness, of target cells in bone.

Child↗

Effect of tolazoline in pulmonary hemorrhage in the newborn.

A neonate severely ill with pulmonary hemorrhage improved on intravenous tolazoline. We suggest that persistent fetal circulation may complicate this disorder and that vasodilator theapy is justified when other therapeutic measures fail.

Female↗

Nephrocalcinosis, hypercalciuria and elevated serum levels of 1,25-dihydroxyvitamin D in children. Possible link to vitamin D toxicity.

Ten children age 1 1/2 to 14 years, had bilateral nephrocalcinosis and hypercalciuria, but normal serum calcium (Ca) and phosphate (P) concentrations. Patients with hypercalciuria were divided into absorptive (n = 4) and renal (n = 6) subgroups, and in the latter four patients had a primary Ca-leak and two had a P-leak. All the children had received intermittent high dose vitamin D prophylaxis during infancy. At the time of investigation all had normal serum levels of 25-hydroxyvitamin D, yet all but one had elevated values of 1,25-(OH)2D. Although the hypercalciuria was indistinguishable from the various known forms of idiopathic hypercalciuria, the previous clinical course and the pattern of bone mineral homeostasis suggest that both clinical features, namely nephrocalcinosis and hypercalciuria were related to vitamin D toxicity through various pathogenetic pathways.

Adolescent↗